"We have allocated funding within the grant to conduct independent clinical outcomes studies to assess the impactPainChek® has on resident care within aged care and the impact on the use of medication. This report willbe part of the conclusion of the trial to determine the long-term benefits of PainChek® and support thepotential for long-term funding as part of the Government’s strategic analysis of the Aged Care sector.This significant investment is expected to trigger widespread and long-term use of PainChek® withinAustralian Residential Aged Care and it is already having a positive impact on our international expansionprogram."
It would be great to have PainChek subsidized by the goverment indefinitley. This i like.
PCK Price at posting:
29.5¢ Sentiment: Buy Disclosure: Held
